Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Wenzel, J; Lubos, E; Schnabel, R et al.
Evaluation of eNOS polymorphisms and the risk of future cardiovascular events in the AtheroGene studyEur Heart J. Bd. 27. 2006 S. 129 Suppl 1
Schnabel, R; Messow, CM; Lubos, E et al.
FLT-1 as an early diagnostic marker in acute coronary syndromes (Group Author(s): AtheroGene)Eur Heart J. Bd. 27. 2006 S. 152 Suppl 1
Schlitt, A; Blankenberg, S; Yan, D et al.
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.Nutr Metab Cardiovasc Dis. Bd. 3. 2006 S. 5
Morange, PE; Bickel, C; Nicaud, V et al.
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease.Arterioscler Thromb Vasc Biol. Bd. 26. 2006 S. 2793-2799
Blankenberg, S; Godefroy, T; Poirier, O et al.
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.Circ Res. Bd. 99. 2006 S. 102-108
Fischer, C; Buschmann, K; Blank, M et al.
Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody.Immunogenetics. Bd. 211. 2006 S. 695-699
Sinning, JM; Bickel, C; Messow, CM et al.
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.Eur Heart J. Bd. 27. H. 24. 2006 S. 2962-8
Torzewski, M; Lackner, KJ
Initiation and progression of atherosclerosis - enzymatic or oxidative modification of low-density lipoprotein?Clin Chem Lab Med. Bd. 44. 2006 S. 1389-1394
Warger, T; Hilf, N; Rechtsteiner, G et al.
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.J Biol Chem. Bd. 281. H. 32. 2006 S. 22545-53
Peetz, D; Schweigert, R; Jachmann, N et al.
Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.Clin Lab. Bd. 52. H. 11-12. 2006 S. 605-14